Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Erlotinib Hydrochloride Tablets

Approval Number

国药准字H20213426

Company苏州特瑞药业股份有限公司

Registration Date

June 1, 2021

Drug Information

Generic Name

盐酸厄洛替尼片

Dosage Form

片剂

Strength

150mg

Drug Type

化学药品

Registration Date

June 1, 2021

Company Information

Applicant Company

Company Name苏州特瑞药业股份有限公司

Company Address

苏州高新区浒墅关镇浒青路68号

Manufacturing Company

Company Name苏州特瑞药业股份有限公司

Company Address

苏州高新区浒墅关镇浒青路68号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸厄洛替尼片 - NMPA 批准文号 | MedPath